HKUST polymer-therapeutics platform entering the clinic in dry eye, with osteoarthritis and aesthetics as follow-on indications.
Polymer therapeutics (ophthalmology, osteoarthritis) with first-in-human authorisation: pharma partnering candidate.
Evidence from the records
- “Polymer-based therapeutics (ophthalmology, osteoarthritis, regenerativ”
- “Series A”
- Intro path
- BILIX (Estech portfolio)
- First step
- Explore licensing for Korea.